Sato N, Yabuki Y, Toh K, Ishii Y, Kikuchi K
Immunology. 1979 Mar;36(3):421-6.
The nature of cell-dependent antibody (CDA) and the mechanism of inhibition of antibody-dependent cellular cytotoxicity (ADCC) were studied in the ADCC assay system in which culture cells of methylcholanthrene-induced rat fibrosarcoma (KMT-50) were used as target cells, xenogeneic antiserum (rabbit anti-KMT-50) as the CDA, and human peripheral blood leucocytes (PBL) as effector cells, respectively. By using protein-A Sepharose CL-4B affinity column chromatography of rabbit anti-KMT-50 serum, CDA was shown to bind protein A. Complement dependent-cytotoxicity (CDC), however, was demonstrated in both the adsorbed fraction (eluate) and the non-adsorbed fraction (effluent) to protein A from the same affinity column chromatography. These data confirmed that CDA was IgG with an intact Fc portion. Inhibition of ADCC occurred by pretreatment of effector cells with rabbit anti-effector (human PBL) serum even with extremely small amounts of antiserum. Such inhibition was demonstrated with the eluate but not with the effluent from protein-A Sepharose CL-4B affinity column chromatography of rabbit anti-effector serum. F(ab')2 fragments of the same eluate (IgG) did not inhibit the ADCC activity. These data showed that the inhibition of ADCC was induced by the blocking of Fc receptors of effector cells with the Fc portions of IgG in anti-effector serum. The data obtained indicate the usefulness of protein A in separation and analysis of CDA and in investigation of the inhibitory mechanisms of ADCC.
在抗体依赖细胞介导的细胞毒性(ADCC)检测系统中,研究了细胞依赖抗体(CDA)的性质以及ADCC抑制机制。该检测系统分别使用甲基胆蒽诱导的大鼠纤维肉瘤(KMT - 50)培养细胞作为靶细胞,异种抗血清(兔抗KMT - 50)作为CDA,人外周血白细胞(PBL)作为效应细胞。通过对兔抗KMT - 50血清进行蛋白A琼脂糖凝胶CL - 4B亲和柱层析,显示CDA能与蛋白A结合。然而,在同一亲和柱层析中,蛋白A的吸附部分(洗脱液)和未吸附部分(流出液)均表现出补体依赖细胞毒性(CDC)。这些数据证实CDA是具有完整Fc段的IgG。用兔抗效应细胞(人PBL)血清预处理效应细胞,即使使用极少量抗血清,也会抑制ADCC。兔抗效应细胞血清经蛋白A琼脂糖凝胶CL - 4B亲和柱层析后的洗脱液可证明这种抑制作用,而流出液则不能。同一洗脱液(IgG)的F(ab')2片段不抑制ADCC活性。这些数据表明,抗效应细胞血清中的IgG的Fc段通过阻断效应细胞的Fc受体诱导了ADCC的抑制。所获得的数据表明蛋白A在CDA的分离和分析以及ADCC抑制机制研究中的有用性。